Stock listing
Frankfurt:2M6 Medtronic plc. Aktie
German listing (Frankfurt) of Medtronic plc. · home listing NYSE:MDT
Follow Medtronic plc. into a list and get an email when it puts out news.
Share price · FWB:2M6
€90.92 EUR -0.88 (-1.0%)
Close on Nov 20, 2026
- Day range
- €90.92 – €93.12 EURNov 20, 2026
- Volume
- 1,007 sharesNov 20, 2026
- Market cap
- €116.3B EURAt the close on Nov 20, 2026 · price × 1.28B shares outstanding
- 52-week range
- €62.55 – €94.82 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €158,779 EURMedian day 919 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:MDT · Home | $99.94 USD | -0.78 (-0.8%) | 9,033,491 | $101.42 | $102.61 | $99.60 | $100.72 | Close on Nov 20, 2026 |
| Xetra:2M6 | €92.44 EUR | +0.96 (+1.0%) | 3,187 | €91.70 | €93.16 | €91.70 | €91.48 | Close on Nov 20, 2026 |
| Frankfurt:2M6 | €90.92 EUR | -0.88 (-1.0%) | 1,007 | €91.56 | €93.12 | €90.92 | €91.80 | Close on Nov 20, 2026 |
| LSE:0Y6X | $100.82 USD | +0.44 (+0.4%) | 4,719 | $99.79 | $102.75 | $99.79 | $100.38 | Close on Nov 20, 2026 |
| B3:MDTC34 | 79.16 BRL | +4.68 (+6.3%) | 12 | 74.76 | 79.16 | 74.76 | 74.48 | Close on Nov 19, 2026 |
| Stuttgart:2M6 | €90.88 EUR | -0.94 (-1.0%) | 88 | €91.46 | €93.10 | €90.88 | €91.82 | Close on Nov 20, 2026 |
| Dusseldorf:2M6 | €92.84 EUR | +1.06 (+1.2%) | — | €91.38 | €92.84 | €91.38 | €91.78 | Close on Nov 20, 2026 |
| Munich:2M6 | €91.40 EUR | -0.74 (-0.8%) | — | €91.84 | €91.84 | €91.40 | €92.14 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:2M6 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €91.90 | -1.349 | -1.4% | €92.41 | €92.97 | €90.44 | 3,941 | |
| €93.25 | +0.476 | +0.5% | €93.27 | €93.58 | €92.90 | 1,904 | |
| €92.77 | +4.782 | +5.4% | €88.49 | €94.82 | €86.98 | 1,904 | |
| €87.99 | -0.106 | -0.1% | €88.13 | €88.39 | €87.24 | 1,001 | |
| €88.09 | +1.054 | +1.2% | €86.03 | €88.77 | €84.86 | 1,811 | |
| €87.04 | +0.436 | +0.5% | €87.12 | €87.39 | €86.93 | 12,882 | |
| €86.60 | +2.191 | +2.6% | €85.01 | €86.61 | €84.01 | 15,558 | |
| €84.41 | -0.488 | -0.6% | €83.65 | €86.51 | €82.89 | 6,798 | |
| €84.90 | -0.062 | -0.1% | €84.93 | €85.00 | €84.88 | 815 | |
| €84.96 | -0.379 | -0.4% | €85.20 | €85.20 | €84.81 | 455 | |
| €85.34 | +0.05 | +0.1% | €85.51 | €85.94 | €85.32 | 10,036 | |
| €85.29 | +1.831 | +2.2% | €83.36 | €85.73 | €83.03 | 1,471 | |
| €83.46 | -0.046 | -0.1% | €84.52 | €85.11 | €82.84 | 1,433 | |
| €83.51 | +0.402 | +0.5% | €82.54 | €84.86 | €81.81 | 742 | |
| €83.10 | -0.937 | -1.1% | €83.74 | €84.85 | €82.84 | 647 | |
| €84.04 | -0.503 | -0.6% | €84.55 | €85.54 | €83.92 | 0 | |
| €84.54 | +0.575 | +0.7% | €84.42 | €84.59 | €84.36 | 850 | |
| €83.97 | +1.789 | +2.2% | €83.94 | €84.45 | €83.38 | 951 | |
| €82.18 | +0.606 | +0.7% | €82.18 | €82.44 | €81.33 | 1,122 | |
| €81.57 | +3.095 | +3.9% | €79.24 | €82.43 | €78.74 | 1,076 | |
| €78.48 | -0.191 | -0.2% | €78.04 | €78.55 | €77.01 | 1,388 | |
| €78.67 | +1.365 | +1.8% | €76.92 | €78.98 | €76.73 | 7,842 | |
| €77.31 | -0.053 | -0.1% | €78.11 | €78.65 | €76.71 | 919 | |
| €77.36 | -0.18 | -0.2% | €77.67 | €77.67 | €76.80 | 1,859 | |
| €77.54 | +0.519 | +0.7% | €76.87 | €79.02 | €76.43 | 2,406 | |
| €77.02 | +0.917 | +1.2% | €77.17 | €77.49 | €76.54 | 1,654 | |
| €76.10 | -0.525 | -0.7% | €75.68 | €76.38 | €75.61 | 626 | |
| €76.63 | -0.577 | -0.7% | €76.70 | €76.70 | €76.26 | 1,239 | |
| €77.20 | -1.206 | -1.5% | €78.94 | €79.03 | €77.01 | 155 | |
| €78.41 | +0.546 | +0.7% | €77.60 | €79.12 | €77.15 | 3,321 | |
| €77.86 | -0.422 | -0.5% | €77.47 | €78.11 | €76.05 | 2,980 | |
| €78.29 | -0.643 | -0.8% | €78.92 | €79.59 | €77.35 | 600 | |
| €78.93 | -0.917 | -1.1% | €80.02 | €80.51 | €78.73 | 673 | |
| €79.85 | -0.693 | -0.9% | €79.88 | €81.18 | €79.65 | 1,939 | |
| €80.54 | -0.685 | -0.8% | €80.64 | €80.64 | €79.97 | 1,313 | |
| €81.22 | -0.283 | -0.3% | €81.31 | €81.40 | €80.76 | 320 | |
| €81.51 | -0.017 | 0.0% | €81.40 | €81.72 | €80.67 | 1,277 | |
| €81.52 | +0.61 | +0.8% | €81.86 | €81.97 | €79.94 | 527 | |
| €80.91 | -0.054 | -0.1% | €80.36 | €81.01 | €80.15 | 331 | |
| €80.97 | +2.345 | +3.0% | €79.33 | €81.71 | €79.11 | 675 | |
| €78.62 | -0.113 | -0.1% | €79.02 | €79.17 | €78.31 | 316 | |
| €78.74 | -0.58 | -0.7% | €79.45 | €79.71 | €78.71 | 27 | |
| €79.32 | -1.086 | -1.4% | €79.63 | €80.19 | €79.18 | 90 | |
| €80.40 | -2.388 | -2.9% | €80.76 | €81.84 | €79.37 | 717 | |
| €82.79 | +2.32 | +2.9% | €81.45 | €82.88 | €79.78 | 193 | |
| €80.47 | +1.00 | +1.3% | €79.75 | €80.89 | €79.19 | 770 | |
| €79.47 | -0.191 | -0.2% | €79.28 | €80.01 | €79.00 | 145 | |
| €79.66 | +0.104 | +0.1% | €79.68 | €80.63 | €79.00 | 802 | |
| €79.56 | +1.055 | +1.3% | €79.78 | €84.72 | €79.16 | 2,221 | |
| €78.50 | +0.425 | +0.5% | €78.51 | €79.72 | €78.32 | 1,032 | |
| €78.08 | -0.015 | 0.0% | €78.60 | €78.77 | €77.88 | 154 | |
| €78.09 | -0.676 | -0.9% | €78.89 | €78.89 | €77.44 | 656 | |
| €78.77 | -0.282 | -0.4% | €77.82 | €79.87 | €77.76 | 690 | |
| €79.05 | -0.802 | -1.0% | €79.07 | €79.09 | €78.96 | 257 | |
| €79.85 | -0.284 | -0.4% | €79.92 | €81.27 | €79.62 | 2,387 | |
| €80.14 | +0.279 | +0.3% | €79.04 | €80.19 | €78.12 | 26 | |
| €79.86 | -0.274 | -0.3% | €80.47 | €80.48 | €79.50 | 463 |
- Ticker
- Frankfurt:2M6
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 17, 2026
Medtronic announces FDA clearance of general surgery procedures for the Hugo™ robotic-assisted surgery (RAS) system
Latest earnings call · Sep 1, 2026
Medtronic PLC. (NYSE:MDT) Q1 2027 Earnings Call
Replay and transcript
Latest deck · Sep 1, 2026
Q1 FY27 Earnings Presentation
Earnings · 24 slides
Latest news
Medtronic to announce financial results for its second quarter of fiscal year 2027
Nov 4, 2026
Closed €93.25 (+0.5%) on Nov 5, 2026
Michael J. Fox Foundation and Medtronic Partner to Help More People with Parkinson's Understand Deep Brain Stimulation
Nov 4, 2026
Closed €92.77 (+5.4%) on Nov 4, 2026
TCT26: Medtronic Symplicity blood pressure procedure shows significant blood pressure drops in SPYRAL AFFIRM real-world study
Nov 3, 2026
Closed €92.77 (+5.4%) on Nov 4, 2026
Medtronic announces positive results from real-world registries for the Sphere-9™ catheter and PulseSelect™ PFA System at APHRS 2026
Oct 22, 2026
Closed €85.29 (+2.2%) on Oct 22, 2026
Medtronic receives CE Mark for next-generation portfolio of pacemakers engineered for conduction system pacing
Oct 19, 2026
Closed €83.10 (-1.1%) on Oct 19, 2026
Medtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS™ surgical system and Corsano™* multi-parameter wearable
Oct 15, 2026
Closed €84.04 (-0.6%) on Oct 16, 2026
Medtronic Completes Separation of MiniMed Group, Inc.
Oct 15, 2026
Closed €84.04 (-0.6%) on Oct 16, 2026
Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer
Oct 14, 2026
Closed €83.97 (+2.2%) on Oct 14, 2026
Medtronic plc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 96 in the last 12 months · 121 in all · newest Nov 17, 2026 · oldest 2025
- Calls
- 31 calls with a replay · 31 with a transcript · latest Sep 1, 2026
- Decks
- 130 decks · latest Sep 1, 2026
Where Medtronic plc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:MDT · Home listing | NYSE | United States | USD |
| BCBA:MDT | BCBA | Argentina | ARS |
| Xetra:2M6 | Xetra | Germany | EUR |
| gettex:2M6 | gettex | Germany | EUR |
| Tradegate:2M6 | Tradegate | Germany | EUR |
| LS Exchange:A14M2J | LS Exchange | Germany | EUR |
| Frankfurt:2M6 · This page | Frankfurt | Germany | EUR |
| Milan:1MDT | Milan | Italy | EUR |
| BMV:MDTN | BMV | Mexico | MXN |
| Lang & Schwarz:A14M2J | Lang & Schwarz | Germany | EUR |
| LSE:0Y6X | LSE | United Kingdom | USD |
| BCBA:MDTD | BCBA | Argentina | USD |
| SIX Swiss:MDT | SIX Swiss | Switzerland | CHF |
| EUROTLX:4MDT | EUROTLX | Italy | EUR |
| B3:MDTC34 | B3 | Brazil | BRL |
| SIX Swiss:MDT.USD | SIX Swiss | Switzerland | USD |
| BOATS:MDT | BOATS | United States | USD |
| BSESOF:2M6 | BSESOF | Bulgaria | EUR |
| Stuttgart:2M6 | Stuttgart | Germany | EUR |
| VIE:MDT | Vienna | Austria | EUR |
| Dusseldorf:2M6 | Dusseldorf | Germany | EUR |
| BIVA:MDTN | BIVA | Mexico | MXN |
| Hamburg:2M6 | Hamburg | Germany | EUR |
| Munich:2M6 | Munich | Germany | EUR |
| BCBA:MDTB | BCBA | Argentina | ARS |
| BCBA:MDTC | BCBA | Argentina | USD |
| Hanover:2M6 | Hanover | Germany | EUR |
| Turquoise:MDTN | Turquoise | United Kingdom | USD |
| BX Swiss:2M6 | BX Swiss | Switzerland | CHF |
| BCBA:MDT.CI | BCBA | Argentina | ARS |
Valuation
P/E 24.4× against a median of 30.7×: 5th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Jul 31, 2026 · price Nov 20, 2026
- Enterprise value
- $144.6B USD
- P/E
- 24.4×
- EV/sales
- 3.9×
- EV/EBITDA
- 14.9×
- Price/book
- 2.5×
- Gross margin
- 65.0%
- Operating margin
- 18.1%
- Net margin
- 13.9%
- Debt to equity
- 0.5×
- Beta vs S&P 500
- 0.15
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Medtronic plc. · NYSE:MDT | US$127.8B | US$144.6B | 24.4× | 3.9× | 14.9× | 2.5× | 13.9% | 0.5× | 0.15 |
| Intuitive Surgical, Inc. · NASDAQ:ISRG | US$138.3B | US$134.3B | 46.8× | 11.6× | n/a | 8.7× | 25.5% | 0.0× | 0.90 |
| Stryker Corporation · NYSE:SYK | US$118.0B | US$129.7B | 32.6× | 4.9× | n/a | 5.0× | 13.8% | 0.6× | 0.25 |
| Boston Scientific Corporation · NYSE:BSX | US$60.85B | US$71.15B | 17.4× | 3.4× | n/a | 2.4× | 16.6% | 0.4× | 0.31 |
| Edwards Lifesciences Corporation · NYSE:EW | US$58.56B | US$54.52B | 57.3× | 8.2× | 33.8× | 5.4× | 15.3% | 0.1× | 0.54 |
| Becton, Dickinson and Company · NYSE:BDX | US$57.96B | US$70.76B | 61.6× | 3.2× | 14.8× | 2.4× | 4.2% | 0.6× | 0.29 |
| Siemens Healthineers AG · XETR:SHL | US$52.77B | US$49.52B | 21.7× | 1.9× | 10.3× | 2.4× | 9.4% | 0.0× | n/a |
| GE HealthCare Technologies Inc. · NASDAQ:GEHC | US$36.46B | US$43.61B | 16.9× | 2.0× | 13.7× | 3.1× | 10.0% | 0.9× | 0.65 |
| Alcon AG · SIX:ALC | US$35.86B | US$38.74B | 54.0× | 3.5× | 16.1× | 1.6× | 6.1% | 0.2× | n/a |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A · SZSE:300760 | US$33.36B | US$30.38B | 28.7× | 5.9× | n/a | 5.4× | 22.4% | 0.0× | n/a |
| ResMed Inc. · NYSE:RMD | US$33.14B | US$32.54B | 20.8× | 5.7× | 15.6× | 5.6× | 27.8% | 0.1× | 0.48 |
| Median of the others | US$55.36B | US$52.02B | 30.7× | 4.2× | 15.2× | 4.1× | 14.5% | 0.1× | 0.48 |
Forecasts
17 strong buy · 2 buy · 11 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 106.35 USD · Analysts' mean
- EPS, year to Apr 2027
- 5.98 · 30 analysts
- Revenue, year to Apr 2027
- 38.97B · 28 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Geoff Martha | Chairman & CEO |
| Thierry Piéton | EVP & Chief Financial Officer |
| Alex Gu | SVP & President, Greater China |
| Kweli P. Thompson | Executive Vice President and President, Neuroscience Portfolio |
| Mike Marinaro | EVP & President, Medical Surgical Portfolio and Americas |
| Skip Kiil | EVP & President, Cardiovascular Portfolio |
| Michelle Quinn | EVP, General Counsel & Secretary |
| Ingrid Goldberg | Investor Relations |
| Ryan Weispfenning | Investor Relations |
| Bob Hopkins | SVP & Head of Global Strategy |
| Laura Mauri | SVP & Chief Scientific and Medical Officer |
| Matt Walter | SVP, Human Resources, IT, and Global Communications & Corporate Marketing |
| Rogerio Branco | SVP & Chief Operations and Supply Chain Officer |
| Scott Cundy | SVP & Chief Quality, Development, & Innovation Officer |
| Majid Kaddoumi | SVP & President, Europe, Middle East, Africa & Asia-Pacific (EurAsia) |
Board
| Director | Role |
|---|---|
| Geoff Martha | Chairman & CEO |
Events
- Next results
- Nov 24, 2026
Calls
| Call | When | Status |
|---|---|---|
| Medtronic PLC. (NYSE:MDT) Q2 2027 Earnings Call | Tue, Nov 24, 2026 · 7:30 AM ET | Upcoming |
| Medtronic PLC. (NYSE:MDT) Q1 2027 Earnings Call | Tue, Sep 01, 2026 · 7:45 AM ET | Replay |
| Medtronic PLC. (NYSE:MDT) Q4 2026 Earnings Call | Wed, Jun 03, 2026 · 7:45 AM ET | Replay |
| Medtronic PLC. (NYSE:MDT) Q3 2026 Earnings Call | Tue, Feb 17, 2026 · 8:00 AM ET | Replay |
| Medtronic PLC. (NYSE:MDT) Q2 2026 Earnings Call | Tue, Nov 18, 2025 · 8:00 AM ET | Replay |
| Medtronic PLC. (NYSE:MDT) Q1 2026 Earnings Call | Tue, Aug 19, 2025 · 8:00 AM ET | Replay |
| Medtronic PLC. (NYSE:MDT) Q4 2025 Earnings Call | Wed, May 21, 2025 · 8:00 AM ET | Replay |
| Medtronic PLC. (NYSE:MDT) Q3 2025 Earnings Call | Tue, Feb 18, 2025 · 8:00 AM ET | Replay |
| Medtronic PLC. (NYSE:MDT) Q2 2025 Earnings Call | Tue, Nov 19, 2024 · 8:00 AM ET | Replay |
| Medtronic PLC. (NYSE:MDT) Q1 2025 Earnings Call | Tue, Aug 20, 2024 · 8:00 AM ET | Replay |
All 32 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q1 2027 | Sep 1, 2026 · Before open | +1.5% |
| Q4 2026 | Jun 3, 2026 · Before open | +5.7% |
| Quarter to Jan 31, 2026 | Feb 17, 2026 · Before open | −3.1% |
| Q2 2026 | Nov 18, 2025 · Before open | +4.7% |
| Q1 2026 | Aug 19, 2025 · Before open | −3.1% |
| Q4 2025 | May 21, 2025 · Before open | −2.3% |
| Q3 2025 | Feb 18, 2025 · Before open | −7.3% |
| Q2 2025 | Nov 19, 2024 · Before open | −3.0% |
| Q1 2025 | Aug 20, 2024 · Before open | +0.7% |
| Q4 2024 | May 23, 2024 · Before open | −5.1% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2024 | Feb 20, 2024 · Before open | +1.7% |
| Q2 2024 | Nov 21, 2023 · Before open | +4.6% |
| Q1 2024 | Aug 22, 2023 · Before open | +2.6% |
| Q4 2023 | May 25, 2023 · Before open | −4.5% |
| Q3 2023 | Feb 21, 2023 · Before open | +0.8% |
| Q2 2023 | Nov 22, 2022 · Before open | −5.3% |
| Q1 2023 | Aug 23, 2022 · Before open | −3.1% |
| Q4 2022 | May 26, 2022 · Before open | −5.8% |
| Q3 2022 | Feb 22, 2022 · Before open | +3.1% |
| Q2 2022 | Nov 23, 2021 · Before open | −3.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 FY27 Earnings Presentation | Earnings | 24 slides | Sep 1, 2026 |
| Q4 2026 Earnings Presentation | Earnings | 28 slides | Jun 3, 2026 |
| ESG Presentation (March 2026) | Sustainability | 36 slides | March 2026 |
| Q3 2026 Earnings Presentation | Earnings | 24 slides | Feb 17, 2026 |
| PowerPoint quick reference guide | 33 slides | January 2026 | |
| PowerPoint quick reference guide | 43 slides | January 2026 | |
| Investor Presentation (January 2026) | Investor deck | 22 slides | January 2026 |
| Q2 2026 Earnings Presentation | Earnings | 23 slides | Nov 18, 2025 |
| Technical Presentation (November 2025) | Technical | 17 slides | Nov 13, 2025 |
| Q1 2026 Earnings Presentation | Earnings | 27 slides | Aug 19, 2025 |
Show 50 decks
This page holds 50 of 130 decks. Open Decks
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36.4B | 33.5B | 32.4B | 31.2B | 31.7B | 30.1B | 28.9B | 30.6B | 30.0B | 29.7B |
| Cost of revenue | 12.7B | 11.6B | 11.2B | 10.7B | 10.1B | 10.5B | 9.42B | 9.15B | 9.07B | 9.29B |
| Gross profit | 23.6B | 21.9B | 21.1B | 20.5B | 21.5B | 19.6B | 19.5B | 21.4B | 20.9B | 20.4B |
| Research and development | 2.87B | 2.73B | 2.73B | 2.70B | 2.75B | 2.49B | 2.33B | 2.33B | 2.26B | 2.19B |
| Selling, general and administrative | 11.8B | 10.8B | 10.7B | 10.4B | 10.3B | 10.1B | 10.1B | 10.4B | 10.2B | 10.0B |
| Operating income | 6.47B | 5.96B | 5.14B | 5.49B | 5.75B | 4.48B | 4.79B | 6.27B | 6.64B | 5.38B |
| Depreciation and amortization | 2.96B | 2.86B | 2.65B | 2.70B | 2.71B | 2.70B | 2.66B | 2.66B | 2.64B | 2.92B |
| EBITDA | 9.43B | 8.82B | 7.79B | 8.18B | 8.46B | 7.19B | 7.45B | 8.93B | 9.28B | 8.30B |
| Interest expense | 715.0M | 729.0M | 719.0M | 636.0M | 553.0M | 925.0M | 1.09B | 1.44B | 1.15B | 1.09B |
| Income before tax | 6.14B | 5.63B | 4.84B | 5.36B | 5.52B | 3.90B | 4.05B | 5.20B | 5.67B | 4.60B |
| Income tax | 1.30B | 936.0M | 1.13B | 1.58B | 456.0M | 265.0M | -751.0M | 547.0M | 2.58B | 578.0M |
| Net income | 4.80B | 4.66B | 3.68B | 3.76B | 5.04B | 3.61B | 4.79B | 4.63B | 3.10B | 4.03B |
| Earnings per share, basic | 3.75 | 3.63 | 2.77 | 2.83 | 3.75 | 2.68 | 3.57 | 3.44 | 2.29 | 2.92 |
| Earnings per share, diluted | 3.73 | 3.61 | 2.76 | 2.82 | 3.73 | 2.66 | 3.54 | 3.41 | 2.27 | 2.89 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.95B | 2.22B | 1.28B | 1.54B | 3.71B | 3.59B | 4.14B | 4.39B | 3.67B | 4.97B |
| Short-term investments | 7.27B | 6.75B | 6.72B | 6.42B | 6.86B | 7.22B | 6.81B | 5.46B | 7.56B | 8.74B |
| Receivables | 6.64B | 6.51B | 6.13B | 6.00B | 5.55B | 5.46B | 4.64B | 6.22B | 5.99B | 5.59B |
| Inventory | 5.95B | 5.48B | 5.22B | 5.29B | 4.62B | 4.31B | 4.23B | 3.75B | 3.58B | 3.34B |
| Current assets | 24.8B | 23.8B | 21.9B | 21.7B | 23.1B | 22.5B | 22.0B | 22.0B | 23.0B | 24.9B |
| Property, plant and equipment | 7.42B | 6.84B | 6.13B | 5.57B | 5.41B | 5.22B | 4.83B | 4.67B | 4.60B | 4.36B |
| Goodwill | 42.6B | 41.7B | 41.0B | 41.4B | 40.5B | 42.0B | 39.8B | 40.0B | 39.5B | 38.5B |
| Total assets | 93.0B | 91.7B | 90.0B | 90.9B | 91.0B | 93.1B | 90.7B | 89.7B | 91.4B | 99.9B |
| Accounts payable | 2.64B | 2.45B | 2.41B | 2.66B | 2.28B | 2.11B | 2.00B | 1.95B | 1.63B | 1.55B |
| Current liabilities | 11.7B | 12.9B | 10.8B | 9.05B | 12.4B | 8.51B | 10.4B | 8.47B | 10.1B | 14.3B |
| Long-term debt | 26.2B | 25.6B | 23.9B | 24.3B | 20.4B | 26.4B | 22.1B | 24.6B | 23.7B | 25.9B |
| Total debt | 24.9B | 25.4B | 25.8B | 33.4B | ||||||
| Total liabilities | 43.0B | 43.4B | 39.6B | 39.3B | 38.3B | 41.5B | 39.8B | 39.5B | 40.6B | 49.5B |
| Shareholders' equity | 49.5B | 48.0B | 50.2B | 51.5B | 52.6B | 51.4B | 50.7B | 50.1B | 50.7B | 50.2B |
| Shares outstanding | 1.28B | 1.28B | 1.31B | 1.33B | 1.33B | 1.35B | 1.34B | 1.34B | 1.35B | 1.37B |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 7.33B | 7.04B | 6.79B | 6.04B | 7.35B | 6.24B | 7.23B | 7.01B | 4.68B | 6.88B |
| Capital spending | -1.90B | -1.86B | -1.59B | -1.46B | -1.37B | -1.35B | -1.21B | -1.13B | -1.07B | -1.25B |
| Free cash flow | 5.43B | 5.18B | 5.20B | 4.58B | 5.98B | 4.88B | 6.02B | 5.87B | 3.62B | 5.63B |
| Cash from investing | -2.93B | -1.94B | -2.37B | -3.49B | -1.66B | -2.87B | -3.20B | -774.0M | 5.86B | -1.57B |
| Cash from financing | -4.75B | -4.36B | -4.45B | -4.96B | -5.34B | -4.14B | -4.20B | -5.43B | -12.0B | -3.28B |
| Dividends paid | -3.64B | -3.59B | -3.67B | -3.62B | -3.38B | -3.12B | -2.89B | -2.69B | -2.49B | -2.38B |
| Share buybacks | -1.03B | -3.23B | -2.14B | -645.0M | -2.54B | -652.0M | -1.33B | -2.88B | -2.17B | -3.54B |
| Change in cash | -269.0M | 934.0M | -259.0M | -2.17B | 121.0M | -547.0M | -253.0M | 724.0M | -1.30B | 2.09B |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G · Big-stake notice | Nov 10, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 21, 2026 | Insider trade | SEC |
| 11-K · Annual report of an employee plan | Oct 21, 2026 | Annual report | SEC |
| 11-K · Annual report of an employee plan | Oct 21, 2026 | Annual report | SEC |
| 8-K · Current report | Oct 19, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Oct 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 16, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 16, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 16, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 144 · Notice of proposed sale | Oct 15, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 15, 2026 | Other filings | SEC |
| SC TO-I/A | Oct 14, 2026 | Acquisition or disposal | SEC |
| 425 | Oct 14, 2026 | Other filings | SEC |
| SC TO-I/A | Oct 13, 2026 | Acquisition or disposal | SEC |
| 425 | Oct 13, 2026 | Other filings | SEC |
| 425 | Oct 9, 2026 | Other filings | SEC |
| 425 | Oct 8, 2026 | Other filings | SEC |
| SC TO-I/A | Oct 8, 2026 | Acquisition or disposal | SEC |
| 425 | Oct 8, 2026 | Other filings | SEC |
| 425 | Oct 7, 2026 | Other filings | SEC |
| 425 | Oct 7, 2026 | Other filings | SEC |
| 425 | Oct 6, 2026 | Other filings | SEC |
| 425 | Oct 5, 2026 | Other filings | SEC |
| 425 | Oct 2, 2026 | Other filings | SEC |
| 425 | Oct 1, 2026 | Other filings | SEC |
| 425 | Sep 30, 2026 | Other filings | SEC |
| 425 | Sep 29, 2026 | Other filings | SEC |
| 425 | Sep 28, 2026 | Other filings | SEC |
| 425 | Sep 25, 2026 | Other filings | SEC |
| 425 | Sep 25, 2026 | Other filings | SEC |
| 425 | Sep 24, 2026 | Other filings | SEC |
| 425 | Sep 23, 2026 | Other filings | SEC |
| 425 | Sep 22, 2026 | Other filings | SEC |
| 425 | Sep 21, 2026 | Other filings | SEC |
| 425 | Sep 21, 2026 | Other filings | SEC |
| 425 | Sep 21, 2026 | Other filings | SEC |
| 425 | Sep 18, 2026 | Other filings | SEC |
| 425 | Sep 17, 2026 | Other filings | SEC |
| SC TO-I/A | Sep 17, 2026 | Acquisition or disposal | SEC |
| 425 | Sep 17, 2026 | Other filings | SEC |
| 8-K · Current report | Sep 17, 2026 | Current report | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 425 | Sep 16, 2026 | Other filings | SEC |
| 425 | Sep 16, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 16, 2026 | Other filings | SEC |
| 425 | Sep 15, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| SC TO-I | Sep 14, 2026 | Acquisition or disposal | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| IRANNOTICE | Sep 3, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Sep 3, 2026 | Quarterly report | SEC |
| 8-K · Current report | Sep 1, 2026 | Results | SEC |
| 4 · Change in ownership | Aug 24, 2026 | Insider trade | SEC |
| ARS · Annual report to shareholders | Aug 24, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Aug 17, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Aug 17, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 9, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 8, 2026 | Other filings | SEC |
| 3 · Initial statement of ownership | Jun 26, 2026 | Insider trade | SEC |
| IRANNOTICE | Jun 18, 2026 | Other filings | SEC |
| 10-K · Annual report | Jun 18, 2026 | Annual report | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 8, 2026 | Other filings | SEC |
| 8-K · Current report | Jun 3, 2026 | Results | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| SD · Specialized disclosure | May 28, 2026 | ESG report | SEC |
| 8-K · Current report | May 18, 2026 | Management or board change | SEC |
| SCHEDULE 13G · Big-stake notice | May 6, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 28, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Apr 24, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Mar 24, 2026 | Current report | SEC |
| S-3ASR · Registration statement | Mar 9, 2026 | Offer document | SEC |
| 3 · Initial statement of ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Feb 24, 2026 | Quarterly report | SEC |
| 144 · Notice of proposed sale | Feb 19, 2026 | Other filings | SEC |
| 8-K · Current report | Feb 17, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 2, 2026 | Insider trade | SEC |
| SCHEDULE 13D · Big-stake notice | Jan 29, 2026 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Jan 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 9, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Dec 3, 2025 | Big-stake notice | SEC |
| IRANNOTICE | Nov 25, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 25, 2025 | Quarterly report | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 21, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 19, 2025 | Other filings | SEC |
| 8-K · Current report | Nov 18, 2025 | Results | SEC |
| 8-K · Current report | Nov 3, 2025 | Management or board change | SEC |
| 11-K/A · Annual report of an employee plan, amended | Oct 24, 2025 | Annual report | SEC |
| 11-K/A · Annual report of an employee plan, amended | Oct 24, 2025 | Annual report | SEC |
| 8-K · Current report | Oct 21, 2025 | Meeting outcome | SEC |
| 11-K · Annual report of an employee plan | Oct 20, 2025 | Annual report | SEC |
| 11-K · Annual report of an employee plan | Oct 20, 2025 | Annual report | SEC |
| 25-NSE | Oct 15, 2025 | Other filings | SEC |
| 25-NSE | Sep 29, 2025 | Other filings | SEC |
| CERT · Exchange's certificate of listing | Sep 29, 2025 | Other filings | SEC |
| 8-A12B · Registration of shares for listing on an exchange | Sep 29, 2025 | Other filings | SEC |
| 8-K · Current report | Sep 29, 2025 | Material contract | SEC |
| 8-K · Current report | Sep 16, 2025 | Current report | SEC |
| 424B5 · Prospectus | Sep 16, 2025 | Offer document | SEC |
| FWP · Free writing prospectus | Sep 15, 2025 | Offer document | SEC |
| 424B3 · Prospectus | Sep 15, 2025 | Offer document | SEC |
| 4 · Change in ownership | Sep 5, 2025 | Insider trade | SEC |
| ARS · Annual report to shareholders | Sep 4, 2025 | Annual report | SEC |
| 144 · Notice of proposed sale | Sep 3, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 26, 2025 | Quarterly report | SEC |
| IRANNOTICE | Aug 26, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 25, 2025 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Aug 25, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Aug 25, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Aug 21, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 19, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 19, 2025 | Insider trade | SEC |
| 8-K · Current report | Aug 19, 2025 | Results | SEC |
| PRE 14A · Preliminary proxy statement | Aug 5, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 28, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 2, 2025 | Insider trade | SEC |
| 25-NSE | Jul 2, 2025 | Other filings | SEC |
| 8-K · Current report | Jun 23, 2025 | Management or board change | SEC |
| IRANNOTICE | Jun 20, 2025 | Other filings | SEC |
| 10-K · Annual report | Jun 20, 2025 | Annual report | SEC |
| 144 · Notice of proposed sale | Jun 6, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 4, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 4, 2025 | Insider trade | SEC |
| SD · Specialized disclosure | May 28, 2025 | ESG report | SEC |
| 8-K · Current report | May 21, 2025 | Results | SEC |
| 4 · Change in ownership | May 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 30, 2025 | Insider trade | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Medtronic plc.’s releases
- Common shares
- 1,279,137,890
- Fully diluted
- 1,279,137,890
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 1,279,137,890 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 1,279,137,890 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Martha G. Aronson Other companies: Merit Medical Systems, Inc. (President and Chief Executive Officer · Since at least Oct 3, 2025); CONMED Corporation (Director · Since at least Feb 23, 2016); Cardiovascular Systems Inc (Director · Feb 20, 2017 – Apr 27, 2023 · Past); Methode Electronics, Inc. (Director · Apr 19, 2016 – Jul 2, 2019 · Past); Ecolab Inc. (EVP & Pres.-Global Healthcare · May 8, 2014 – Aug 1, 2015 · Past); Hill-Rom Holdings Inc (Sr. VP & Pres. N. America · Aug 2, 2010 – Nov 29, 2011 · Past); Hutchinson Technology Inc (Director · Jun 2, 2010 – Oct 5, 2016 · Past) | SrVP Chief Talent Officer · Mar 10, 2008 – Oct 30, 2009 · Past |
| Michael J. Coyle Other companies: Integer Holdings Corporation (Director · Since at least Jul 10, 2025); Haemonetics Corporation (Director · Since at least Apr 16, 2020); iRhythm Holdings, Inc. (President and CEO, Director · Jan 12, 2021 – Feb 24, 2021 · Past); Volcano Corp (Director · Apr 30, 2009 – May 23, 2012 · Past); Vnus Medical Technologies Inc (Director · May 25, 2006 – Jun 17, 2009 · Past); St. Jude Medical Inc (President, CRMD · Feb 1, 2006 – Jun 20, 2007 · Past) | EVP & Group Pres, Cardiac&Vasc · Dec 14, 2009 – Nov 3, 2020 · Past |
| Bryan Hanson Other companies: Solventum Corporation (Chief Executive Officer · Since at least Apr 1, 2024); Walgreens Boots Alliance Inc (Director · Since at least Oct 27, 2022); 3M Company (Group Pres & CEO Health Care · Sep 1, 2023 – Sep 1, 2023 · Past); Zimmer Biomet Holdings, Inc. (President and CEO, Director · Dec 19, 2017 – Mar 6, 2023 · Past); Covidien plc (Senior Vice President · May 3, 2013 – Jan 26, 2015 · Past) | EVP, President, MITG · Jan 26, 2015 – Dec 15, 2017 · Past |
| Craig Arnold Other companies: Honeywell Aerospace Inc (Director · Since at least Jun 29, 2026); Honeywell International Inc. (Director · Since at least Nov 3, 2025); KKR & Co. Inc. (Director · Since at least Sep 23, 2025); Procter & Gamble Company (the) (Director · Since at least Jun 9, 2025); Eaton Corporation, PLC (See Remarks below., Director · Jun 1, 2016 – May 12, 2025 · Past) | Director · Since at least Apr 27, 2016 |
| Gregory D. Smith Other companies: Advance Auto Parts Inc. (Independent Director · Since at least Mar 11, 2024); American Airlines Group, Inc. (Director · Since at least Jan 18, 2022); Intel Corporation (Director · Since at least Mar 23, 2017); Boeing Company (the) (Director · Feb 9, 2010 – Nov 5, 2026 · Past) | EVP Global Ops & Supply Chain · Since at least Jul 29, 2024 |
| Randall J. Hogan Other companies: Kodiak Gas Services, Inc. (Independent Chairperson of the Board · Since at least Jun 28, 2023); nVent Electric plc (Director · Apr 30, 2018 – May 17, 2024 · Past); Pentair plc. (Chairman & Chief Exec. Officer, Director · Nov 21, 2011 – Apr 17, 2018 · Past); Covidien plc (Director · Nov 4, 2011 – Jan 26, 2015 · Past) | Director · Since at least Jan 26, 2015 |
| Richard Kuntz Other companies: DiaMedica Therapeutics Inc. (Director · Since at least May 30, 2023); Identiv, Inc. (Director · Since at least Oct 18, 2022); ZimVie Inc (Director · Since at least Mar 1, 2022); Rockley Photonics Holdings Ltd (Director · Aug 8, 2022 – Aug 8, 2022 · Past) | SVP & Chief Medical & Science · Jan 9, 2018 – Nov 5, 2021 · Past |
| Scott R. Ward Other companies: Merit Medical Systems, Inc. (Member - Governance & Sustainability Committee, Finance & Operating Committee · Since at least May 13, 2026); InspireMD Inc. (Board Member · Since at least Nov 25, 2024); Cardiovascular Systems Inc (Chairman and CEO, Director · Nov 13, 2013 – Apr 27, 2023 · Past); SurModics Inc (Director · Sep 20, 2010 – Dec 3, 2014 · Past) | SVP & Pres CardioVascular · Apr 30, 2010 – Apr 30, 2010 · Past |
| Elizabeth Nabel Other companies: Lyell Immunopharma, Inc. (Director · Since at least Jun 16, 2021); Moderna, Inc. (Director · Since at least Dec 7, 2018); Accolade, Inc. (Director · Jun 2, 2021 – Apr 8, 2025 · Past) | Director · Since at least Sep 16, 2014 |
| Ivan K. Fong Other companies: Cboe Global Markets, Inc. (Board Member · Since at least Dec 17, 2020); 3M Company (Exec VP, Gen Counsel & Secret · Oct 15, 2012 – Apr 30, 2021 · Past); Cardinal Health, Inc. (CLO & Secretary · Nov 1, 2008 – Nov 1, 2008 · Past) | EVP GENERAL COUNSEL & SECR · Feb 1, 2022 – Dec 16, 2024 · Past |
All 50 people
| Person | Seat |
|---|---|
| Karen Parkhill Other companies: HP Inc. (Chief Financial Officer · Since at least Aug 5, 2024); American Express Company (Director · Since at least Jan 29, 2020); Comerica Incorporated (Vice Chairman · Aug 8, 2011 – May 5, 2016 · Past) | EVP & Chief Financial Officer · Jun 20, 2016 – Aug 2, 2024 · Past |
| Antonio M Md D Phil Gotto Jr Other companies: Esperion Therapeutics, Inc. (Director · Jan 13, 2014 – May 23, 2024 · Past); Aegerion Pharmaceuticals Inc (Director · Oct 21, 2010 – Nov 29, 2016 · Past) | Director · Aug 24, 2006 – Aug 24, 2006 · Past |
| Bradley E. Lerman Other companies: Starbucks Corporation (evp, chief legal officer · Since at least Apr 17, 2023); McKesson Corporation (Director · Since at least Apr 24, 2018) | SVP General Counsel & Corp Sec · May 27, 2014 – Nov 5, 2021 · Past |
| Denise M Oleary Other companies: American Airlines Group, Inc. (Director · Since at least Jun 13, 2018); Calpine Corporation (Director · Mar 8, 2018 – Mar 8, 2018 · Past) | Director · Apr 17, 2018 – May 1, 2024 · Past |
| Jennifer M. Kirk Other companies: DBA Sempra (Director · Since at least Jun 20, 2024); Republic Services, Inc. (Director · Since at least Oct 15, 2020) | Chief Accounting Officer · Jun 30, 2021 – Dec 6, 2024 · Past |
| John P Groetelaars Other companies: Dentsply Sirona Inc. (Interim Chief Executive Office, Director · Apr 6, 2022 – Apr 14, 2023 · Past); Hill-Rom Holdings Inc (Chief Executive Officer, Director · Nov 6, 2019 – Dec 13, 2021 · Past) | Director · Since at least Aug 19, 2025 |
| Kevin E Lofton Other companies: MiniMed Group, Inc. (Director · Since at least Mar 6, 2026); Gilead Sciences, Inc. (Director · Dec 28, 2023 – Mar 28, 2024 · Past) | Director · Since at least Apr 29, 2024 |
| Caroline Stockdale Other companies: First Solar, Inc. (Chief People and Communications Officer · Since at least Oct 7, 2019) | Sr VP Human Resources · Apr 30, 2010 – Oct 29, 2012 · Past |
| Gary Corona Other companies: nVent Electric plc (EVP & Chief Financial Officer · Since at least Mar 31, 2025) | Interim CFO · Aug 3, 2024 – Jan 21, 2025 · Past |
| Gregory P Lewis Other companies: Honeywell International Inc. (Former SrVP/CFO · Oct 3, 2019 – Feb 17, 2025 · Past) | Director · Since at least Jun 26, 2023 |
| Jean Pierre Rosso Other companies: ADC Telecommunications Inc (Director · Mar 8, 2006 – Mar 8, 2006 · Past) | Director · Aug 31, 2006 – Apr 30, 2012 · Past |
| Laura Mauri Other companies: MiniMed Group, Inc. (Director · Since at least Mar 6, 2026) | SVP & Chief Scientific and Medical Officer · Since at least Nov 5, 2026 |
| Neil P. Ayotte Other companies: Nuwellis, Inc. (General Counsel + Chief Compliance Officer · Since at least Jun 7, 2021) | VP Interim Gen Counsel CorpSec · Jul 15, 2013 – Mar 10, 2014 · Past |
| Ryan Weispfenning Other companies: MiniMed Group, Inc. (Investor Relations · Since at least Apr 28, 2026) | Investor Relations · Since at least Feb 24, 2026 |
| Alex Gu | SVP & President, Greater China · Since at least Nov 4, 2026 |
| Bob Hopkins | SVP & Head of Global Strategy · Since at least Nov 4, 2026 |
| Chris Cleary | Chairman of its Board of Directors · Nov 26, 2025 – Nov 5, 2026 · Past |
| Denise L Blomquist | Chief Accounting Officer · Since at least Mar 17, 2025 |
| Geoff Martha | Chairman & CEO · Since at least Oct 15, 2026 |
| Ingrid Goldberg | Investor Relations · Since at least Oct 7, 2026 |
| James T Lenehan | Director · Mar 13, 2018 – May 3, 2021 · Past |
| Joon Sup Lee | Director · Since at least Jun 18, 2025 |
| Kendall J Powell | Director · Since at least Apr 27, 2026 |
| Kweli P. Thompson | Executive Vice President and President, Neuroscience Portfolio · Since at least Jun 18, 2026 |
| Lidia Fonseca | Director · Since at least Apr 27, 2026 |
| Majid Kaddoumi | SVP & President, Europe, Middle East, Africa & Asia-Pacific (EurAsia) · Since at least Nov 5, 2026 |
| Matthew R Walter | SVP, Chief HR Officer · Since at least May 1, 2026 |
| Matt Walter | SVP, Human Resources, IT, and Global Communications & Corporate Marketing · Since at least Aug 4, 2026 |
| Michael Marinaro | President · Since at least Jun 26, 2023 |
| Michelle Quinn | EVP, GC and Secretary · Since at least Jul 28, 2026 |
| Mike Marinaro | EVP & President, Medical Surgical Portfolio and Americas · Since at least May 21, 2026 |
| Reman McDonagh | Vice President, Global Marketing · Jan 29, 2026 – Nov 5, 2026 · Past |
| Robert H Blankemeyer | SVP & Pres Surgical Technol · Oct 27, 2008 – Aug 3, 2009 · Past |
| Robert John White | EVP & Pres. Medical Surgical · Jul 29, 2019 – Dec 8, 2023 · Past |
| Rob Ten Hoedt | EVP and Pres. Global Regions · Oct 9, 2020 – Aug 3, 2023 · Past |
| Rogerio Branco | SVP & Chief Operations and Supply Chain Officer · Since at least Nov 5, 2026 |
| Scott C Donnelly | Director · Since at least Apr 27, 2026 |
| Scott Cundy | SVP & Chief Quality, Development, & Innovation Officer · Since at least Nov 5, 2026 |
| Skip Kiil | EVP & President, Cardiovascular Portfolio · Since at least Apr 20, 2026 |
| Thierry Piéton | EVP & Chief Financial Officer · Since at least Mar 3, 2025 |
Log in to ask 6ix AI your own questions about Medtronic plc.